United States · FDA National Drug Code directory
EVOTAZ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0003-3641_fa642c67-5a9e-4136-a141-64e1236f6a0f
- Product NDC
- 0003-3641
- Form
- TABLET
- Composition / generic term
- atazanavir and cobicistat
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150129
- Source listing expiry
- 20261231
Source-listed ingredients
- ATAZANAVIR SULFATE — 300 mg/1
- COBICISTAT — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (0003-3641-11) · 0003-3641-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →